We are live on ! Find out more
TOIIW

The Oncology Institute Warrant

Delisted

TOIIW was delisted on the 31st of July, 2026.

11 hedge funds and large institutions have $821K invested in The Oncology Institute Warrant in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $818K → $821K (+$3.17K)

8% less funds holding

Funds holding: 1211 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
3
Closed
1
Calls
$13K
Puts
Net Calls
+$13K
Net Calls Change
-$2K

TOIIW Hedge Fund Activity: Q4 2025 in Review

11 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q4 2025, worth a combined $821K — up 0.39% from $818K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of TOIIW and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.

The largest seller was FreeGulliver LLC, exiting entirely with an estimated $9.24K sold.

  • 11 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q4 2025, down from 12 in Q3 2025.
  • Funds reported $821K of The Oncology Institute Warrant stock for Q4 2025, up 0.39% quarter-over-quarter.
  • 0 funds opened new The Oncology Institute Warrant positions in Q4 2025 and 1 closed out, a net change of -1 holder.
  • The largest The Oncology Institute Warrant seller in Q4 2025 was FreeGulliver LLC, an estimated $9.24K sold.

Based on aggregated 13F filings for Q4 2025.